相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma
Gajanan Kendre et al.
JOURNAL OF HEPATOLOGY (2023)
Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma
Lipika Goyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2023)
KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas
Aleksandr S. Martianov et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Targeting BRCA-mutant biliary tract cancer: Current evidence and future perspectives
Xin Yu Li et al.
JOURNAL OF DIGESTIVE DISEASES (2023)
Cholangiocarcinoma - novel biological insights and therapeutic strategies
Sumera I. Ilyas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2023)
Cost-Efficient Detection of NTRK1/2/3 Gene Fusions: Single-Center Analysis of 8075 Tumor Samples
Aleksandr A. Romanko et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Rapid and Cost-Efficient Detection of RET Rearrangements in a Large Consecutive Series of Lung Carcinomas
Vladislav I. Tiurin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies
Justin H. H. Lo et al.
CANCERS (2023)
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation
Bruno Almeida Costa et al.
ONCOLOGY RESEARCH AND TREATMENT (2023)
Preparation of Duplex Sequencing Libraries for Archival Paraffin-Embedded Tissue Samples Using Single-Strand-Specific Nuclease P1
Natalia V. Mitiushkina et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Comprehensive evaluation of the test for 5′-/3′-end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer
Natalia Mitiushkina et al.
CANCER MEDICINE (2022)
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
Daniel Zingg et al.
NATURE (2022)
Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trial
Vivek Subbiah et al.
NATURE MEDICINE (2022)
Target Enrichment Approaches for Next-Generation Sequencing Applications in Oncology
Rajesh R. Singh
DIAGNOSTICS (2022)
Trastuzumab upregulates programmed death ligand-1 expression through interaction with NK cells in gastric cancer
Kohei Yamashita et al.
BRITISH JOURNAL OF CANCER (2021)
The diversity of tumours with microsatellite instability: molecular mechanisms and impact upon microsatellite instability testing and mismatch repair protein immunohistochemistry
Jinru Shia
HISTOPATHOLOGY (2021)
Simultaneous Identification of Cell of Origin, Translocations, and Hotspot Mutations in Diffuse Large B-Cell Lymphoma Using a Single RNA-Sequencing Assay
Rory Crotty et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)
Cholangiocarcinoma with STRN-ALK translocation treated with ALK inhibitors
Marine Valery et al.
DIGESTIVE AND LIVER DISEASE (2021)
Comparison of RNA-Based Next-Generation for Sequencing Assays for the Detection of NTRK Gene Fusions
Hyeon J. Park et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2021)
Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation
Carina Heydt et al.
BMC MEDICAL GENOMICS (2021)
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study
Milind Javle et al.
Lancet Gastroenterology & Hepatology (2021)
FGFR2 Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma
James M. Cleary et al.
CANCER DISCOVERY (2021)
Identification of an EML4-ALK rearrangement in an intrahepatic cholangiocarcinoma
Loetitia Favre et al.
PATHOLOGY INTERNATIONAL (2021)
Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinoma
Michael Bitzer et al.
NPJ PRECISION ONCOLOGY (2021)
Targetable molecular alterations in congenital glioblastoma
Ahmed Gilani et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Intergenic Breakpoints Identified by DNA Sequencing Confound Targetable Kinase Fusion Detection in NSCLC
Weihua Li et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Ivosidenib in IDH1-mutant, chemotherapy-refractory Croatia& cholangiocarcinoma (ClarlDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
Ghassan K. Abou-Alfa et al.
LANCET ONCOLOGY (2020)
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Ghassan K. Abou-Alfa et al.
LANCET ONCOLOGY (2020)
Novel Gene Fusions in Glioblastoma Tumor Tissue and Matched Patient Plasma
Lan Wang et al.
CANCERS (2020)
Narrative review of molecular pathways of kinase fusions and diagnostic approaches for their detection in non-small cell lung carcinomas
Matthias S. Matter et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma
Sarinya Kongpetch et al.
JCO GLOBAL ONCOLOGY (2020)
Response to Crizotinib in ROS1 Fusion-Positive Intrahepatic Cholangiocarcinoma
Christopher D. Jakubowski et al.
JCO PRECISION ONCOLOGY (2020)
Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future Challenges
Alessandro Rizzo et al.
CANCER CONTROL (2020)
High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden
Ryma Benayed et al.
CLINICAL CANCER RESEARCH (2019)
Comparative analysis of expression of mutant and wild-type alleles is essential for reliable PCR-based detection of MET exon 14 skipping
Natalia Mitiushkina et al.
BIOCHIMIE (2019)
Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods
Brian J. Haas et al.
GENOME BIOLOGY (2019)
Frequency and prognostic significance of isocitrate dehydrogenase 1 mutations in cholangiocarcinoma: a systematic literature review
Audra N. Boscoe et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFN gamma secretion
Bharat K. R. Chaganty et al.
CANCER LETTERS (2018)
Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention
Maeve A. Lowery et al.
CLINICAL CANCER RESEARCH (2018)
HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?
Salvatore Galdy et al.
CANCER AND METASTASIS REVIEWS (2017)
UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy
Tom Smith et al.
GENOME RESEARCH (2017)
Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors
Kinga Szurian et al.
PATHOBIOLOGY (2017)
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Apinya Jusakul et al.
CANCER DISCOVERY (2017)
Rare Incidence of ROS1 Rearrangement in Cholangiocarcinoma
Sun Min Lim et al.
CANCER RESEARCH AND TREATMENT (2017)
The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing
Teresa Helsten et al.
CLINICAL CANCER RESEARCH (2016)
Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice
Apurva Jain et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)
Fibroblast Growth Factor Receptor 2 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Cholangiocarcinoma
Yasuhito Arai et al.
HEPATOLOGY (2014)
Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma
Rondell P. Graham et al.
HUMAN PATHOLOGY (2014)
BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma
Benjamin Goeppert et al.
MODERN PATHOLOGY (2014)
Anchored multiplex FOR for targeted next-generation sequencing
Zongli Zheng et al.
NATURE MEDICINE (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Human housekeeping genes, revisited
Eli Eisenberg et al.
TRENDS IN GENETICS (2013)
Liver Flukes: the Malady Neglected
Jae Hoon Lim
KOREAN JOURNAL OF RADIOLOGY (2011)
A guide for in-house design of template-switch-based 5′ rapid amplification of cDNA ends systems
Fernando Lopes Pinto et al.
ANALYTICAL BIOCHEMISTRY (2010)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
3′ rapid amplification of cDNA ends (RACE) walking for rapid structural analysis of large transcripts
T Ozawa et al.
JOURNAL OF HUMAN GENETICS (2004)